Proteomic and lipidomic analyses of paraoxonase defined high density lipoprotein particles: Association of paraoxonase with the anti-coagulant, protein S.

Xenia Moren, Marie Lhomme, Alexandre Bulla, Jean-Charles Sanchez, Anatol Kontush, Richard W James

Journal: Proteomics. Clinical applications 2017;10(3):230-8

PMID: 26358807

Abstract

PURPOSE

Characterizing high density lipoprotein (HDL) particles and their relevance to HDL function is a major research objective. One aim is to identify functionally distinct particles. To try to limit both functional and compositional heterogeneity the present study focused on paraoxonase-1 (PON1) as a target for isolation of a minor HDL subfraction.

EXPERIMENTAL DESIGN

Immunoaffinity techniques were applied to isolate PON1-containing HDL (P-HDL) and total HDL (T-HDL), which were subsequently characterized and compared.

RESULTS

Analyses of the lipidomes showed significant differences between the fractions in the relative concentrations of individual lipid subspecies, notably reduced levels of unsaturated lysophosphatidylcholine (p < 0.05) in P-HDL (reflected in a significantly reduced total lysophosphatidylcholine polyunsaturated fatty acid content, p < 0.004). Significant differences were also observed for the proteomes. P-HDL was highly enriched in the anti-coagulant, vitamin K activated protein S (prot S) (p < 0.0001), and alpha2 macroglobulin (p < 0.01), compared to T-HDL. Conversely, procoagulant proteins kininogen 1 and histidine-rich glycoprotein were largely excluded from P-HDL. Immunoabsorption of PON1 from plasma significantly reduced prot S anti-coagulant activity.

CONCLUSIONS AND CLINICAL RELEVANCE

The P-HDL lipidome and proteome showed significant differences from T-HDL. Enrichment in anti-coagulation proteins indicates complementary functionalities within P-HDL particles and underlines their anti-atherosclerotic potential.

© 2015 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim.

Address: Clinical Diabetes Unit, Department of Medical Specialities, Medical Faculty, University of Geneva, Geneva, Switzerland.; INSERM, UMR-ICAN, 1166, University of Pierre and Marie Curie - Paris 6, Pitié - Salpétrière University Hospital, Paris, France.; Department of Genetic and Laboratory Medicine, University Hospital, Geneva, Switzerland.; Translational Biomarker Group (TBG), Department of Human Protein Sciences, University Medical Centre, University of Geneva, Geneva, Switzerland.

Link outs

Subscription / membership required

Bant logo

© Copyright 2026, Nutrition Evidence

NED wishes to thank the following organisations for their support:

We use cookies to improve your experience and analyze site traffic with Google Analytics. By continuing to use our site, you agree to our use of cookies. Learn more.